Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 5:04 PM View:  | Vyne Therapeutics Inc. (VYNE) | 01-Apr-24 | Payment of Exercise | 161 | $3.08 | $495.88 | (< 1%) 149.44K to 149.27K | |
| 03-Jan-24 5:20 PM View: | Vyne Therapeutics Inc. (VYNE) | 02-Jan-24 | Payment of Exercise | 161 | $2.28 | $367.08 | (< 1%) 149.6K to 149.44K | |
| 03-Jan-24 5:20 PM View: | Vyne Therapeutics Inc. (VYNE) | 01-Jan-24 | Grant | 62,500 | -- | -- | 72% 87.1K to 149.6K | |
| 15-Dec-23 5:09 PM View: | Vyne Therapeutics Inc. (VYNE) | 13-Dec-23 | Grant | 62,500 | -- | -- | 254% 24.6K to 87.1K | |
| 04-Oct-23 4:21 PM View: | Vyne Therapeutics Inc. (VYNE) | 02-Oct-23 | Payment of Exercise | 1,154 | $3.83 | $4,419.82 | (4%) 25.75K to 24.6K | |
| 05-Jul-23 4:32 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-23 | Payment of Exercise | 157 | $4.10 | $643.70 | (< 1%) 25.91K to 25.75K | |
| 02-Jun-23 4:34 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-May-23 | Grant | 3,664 | $3.46 | $12,663.90 | 16% 22.24K to 25.91K | |
| 04-Apr-23 5:03 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-23 | Payment of Exercise | 478 | $3.08 | $1,472.24 | (2%) 22.72K to 22.24K | |
| 22-Mar-23 4:01 PM View: | Vyne Therapeutics Inc. (VYNE) | 20-Mar-23 | Purchase | 10,000 | $2.50 | $25,000.00 | 79% 12.72K to 22.72K | |
| 04-Jan-23 5:12 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-22 | Payment of Exercise | 1,813 | $0.15 | $271.95 | (< 1%) 230.96K to 229.14K | |
| 04-Oct-22 5:04 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-22 | Payment of Exercise | 1,813 | $0.22 | $404.30 | (< 1%) 232.77K to 230.96K | |
| 05-Jul-22 5:00 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-22 | Payment of Exercise | 1,813 | $0.39 | $705.26 | (< 1%) 234.58K to 232.77K | |
| 04-Apr-22 5:09 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-22 | Payment of Exercise | 3,630 | $0.65 | $2,359.50 | (2%) 238.21K to 234.58K | |
| 18-Mar-22 5:09 PM View: | Vyne Therapeutics Inc. (VYNE) | 17-Mar-22 | Grant | 75,000 | -- | -- | 46% 163.21K to 238.21K | |
| 04-Jan-22 4:40 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-21 | Payment of Exercise | 1,484 | $1.02 | $1,513.68 | (< 1%) 164.7K to 163.21K | (17%) |
| 01-Oct-21 5:11 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-21 | Payment of Exercise | 1,484 | $1.39 | $2,062.76 | (< 1%) 166.18K to 164.7K | (< 1%) |
| 03-Sep-21 5:34 PM View: | Vyne Therapeutics Inc. (VYNE) | 02-Sep-21 | Grant | 60,859 | -- | -- | 58% 105.32K to 166.18K | |
| 02-Jul-21 4:36 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-21 | Payment of Exercise | 3,551 | $3.51 | $12,464.00 | (3%) 108.87K to 105.32K | 1% |
| 02-Apr-21 12:14 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-21 | Payment of Exercise | 1,765 | $6.84 | $12,072.60 | (2%) 110.64K to 108.87K | (1%) |
| 24-Feb-21 4:38 PM View: | Vyne Therapeutics Inc. (VYNE) | 22-Feb-21 | Grant | 29,213 | -- | -- | 36% 81.42K to 110.64K | |
| 05-Jan-21 10:00 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-20 | Payment of Exercise | 1,822 | $1.58 | $2,878.76 | (< 1%) 327.52K to 325.7K | 12% |
| 02-Dec-20 4:31 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Nov-20 | Grant | 10,460 | $1.45 | $15,114.70 | 3% 317.06K to 327.52K | |
| 02-Oct-20 4:31 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-20 | Payment of Exercise | 1,822 | $1.66 | $3,024.52 | (< 1%) 318.89K to 317.06K | (6%) |
| 02-Jul-20 4:24 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-20 | Payment of Exercise | 1,822 | $1.73 | $3,152.06 | (< 1%) 320.71K to 318.89K | (3%) |
| 08-May-20 5:53 PM View: | Vyne Therapeutics Inc. (VYNE) | 06-May-20 | Grant | 150,000 | -- | -- | 88% 170.71K to 320.71K | |
| 07-Apr-20 5:22 PM View: | Vyne Therapeutics Inc. (VYNE) | 06-Apr-20 | Payment of Exercise | 4,474 | $1.40 | $6,263.60 | (3%) 175.19K to 170.71K | (27%) |
| 07-Apr-20 5:22 PM View: | Vyne Therapeutics Inc. (VYNE) | 03-Apr-20 | Grant | 118,683 | -- | -- | 210% 56.5K to 175.19K | |
| 02-Apr-20 4:47 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-20 | Payment of Exercise | 1,688 | $2.68 | $4,523.84 | (3%) 58.19K to 56.5K | 34% |
| 11-Mar-20 5:39 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 09-Mar-20 | Disposition | 98,232 | -- | -- | (100%) 98.23K to 0 | |
| 11-Mar-20 5:56 PM View: | Vyne Therapeutics Inc. (VYNE) | 09-Mar-20 | Grant | 58,191 | -- | -- | 100% 0 to 58.19K | |
| 03-Mar-20 4:38 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 02-Mar-20 | Grant | 1,761 | $2.68 | $4,715.08 | 2% 96.47K to 98.23K | (< 1%) |
| 24-Feb-20 6:38 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 24-Feb-20 | Grant | 41,299 | -- | -- | 75% 55.17K to 96.47K | |
| 03-Jan-20 5:23 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 31-Dec-19 | Payment of Exercise | 618 | $3.28 | $2,027.04 | (1%) 55.79K to 55.17K | |
| 03-Dec-19 4:30 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 29-Nov-19 | Grant | 4,284 | $2.16 | $9,249.16 | 8% 51.51K to 55.79K | |
| 02-Oct-19 4:19 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 30-Sep-19 | Payment of Exercise | 463 | $3.07 | $1,421.41 | (< 1%) 51.97K to 51.51K | |
| 03-Jul-19 4:28 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Jul-19 | Market Sale | 639 | $2.35 | $1,501.65 | (1%) 52.61K to 51.97K | (13%) |
| 03-Apr-19 4:42 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Apr-19 | Market Sale | 2,519 | $3.75 | $9,446.25 | (5%) 55.13K to 52.61K | (8%) |
| 03-Jan-19 4:06 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 01-Jan-19 | Grant | 30,127 | -- | -- | 121% 25.0K to 55.13K | |
| 28-Feb-18 4:07 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 27-Feb-18 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K |